Каталог "Библиографии"
| Списание
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial
Matthew J. Matasar; Marcelo Capra; Muhit Ozcan; Katya Sapunarova; et al.
Детайли
- Източник
- The Lancet Oncology; The Lancet Oncology
Допълнителна информация
- Системен №
- 15329